CRISPR Could Make AIDS a Thing of the Past

Considered one of the most important discoveries of the century, CRISPR-Cas9 genetic engineering technology holds great promise not only for treating genetic diseases and cancer but also for treating viral infections. According to a study published in May 2018 in Scientific Reports, CRISPR prevented HIV from multiplying in cells.
AIDS, caused by Human Immunodeficiency Virus (HIV-1) infection, is a major chronic disease affecting more than 35 million people worldwide. Although antiretroviral medicines provide substantial control of HIV infection, there is currently no treatment offering a complete cure. Removing HIV-infected cells from the body is very difficult. When the virus begins to multiply, it integrates its own DNAinto the cells’ chromosomes. In the study, the genes responsible for HIV-1 replication, tat and rev genes, were targeted with CRISPR. A CRISPR-Cas9 system was designed following genetic analyses of 6 major HIV-1 subtypes. Activation of these genes decreased in HIV-infected cells targeted by CRISPR, and viral replication was stopped. No off-target mutations were observed after treatment. No side effects were observed in the cells either.
What Does This Study Mean for Us?
- An effective genetic treatment using CRISPR was developed against HIV infection, which currently cannot be completely cured.
- With CRISPR, HIV genes were effectively removed from human cells, preventing viral growth.
- It must be emphasized that this study has so far been tested only in the laboratory. Human clinical trials will begin very soon.
Sources
CRISPR/Cas9 system targeting regulatory genes of HIV-1 inhibits viral replication in infected T-cell cultures.
Sci Rep, May 2018.
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.